During the rapidly evolving COVID-19 crisis, the Division of Consumer Affairs has taken extraordinary measures to ensure New Jersey is prepared to meet the increased demand for healthcare services. Through our Healthcare Emergency Licensure Program (HELP), we have created pathways for thousands of retired, out-of-state, foreign-licensed, and newly graduated healthcare professionals to quickly become licensed in New Jersey and expand our available healthcare workforce to safely provide quality care to patients during the coronavirus outbreak.
We have also guided NJ healthcare licensees on how to safely practice during the pandemic, and taken steps to prevent drug shortages caused by the inappropriate prescribing and hoarding of drugs being used to fight COVID-19. DCA’s COVID-19 healthcare initiatives include:
for COVID-19 antibodies have been developed, but data is lacking on what
exactly these tests mean. There is still much that is unknown about COVID-19
infection and antibody testing, click here to see
what is currently known.
The New Jersey Division of Consumer Affairs has issued an Administrative Order which establishes practices and precautions for licensed veterinarians to protect patients, clients, veterinarians, and office staff from the continued risks posed by COVID-19.
For more information click here.
Healthcare Services in Office Practices
Requirement to Co-prescribe an Opioid Antidote (Naloxone)
Pharmacists Authorization to Provide COVID-19 Testing
Rules, Guidance, and Resources
Out-of-State Reciprocity Licensees
Recent Graduate Licensure Program
Reactivated Retiree Licensees
Waivers of Certain Rules to Expand Access to Care